What is the current Glucose IV Bag market size?

The Glucose IV Bag market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Glucose IV Bag market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Glucose IV Bag market?

Key drivers include rising healthcare expenditure and growing prevalence of chronic diseases, fueling future outlook.

What are the challenges facing the Glucose IV Bag market?

Challenges include stringent regulatory requirements and intense competition among manufacturers, impacting market growth.

Which regions are leading the Glucose IV Bag market?

North America and Europe are regional leaders, driven by well-established healthcare infrastructure and high demand.

Who are the top companies in the Glucose IV Bag market?

Top companies include leading pharmaceutical and medical device manufacturers, such as Baxter and Fresenius Kabi.

What future opportunities exist in the Glucose IV Bag market?

Future opportunities include emerging markets and innovative product developments, driving long-term growth prospects.

How is technology impacting the Glucose IV Bag market?

Technology is improving product design, manufacturing, and delivery, enhancing patient outcomes and market efficiency.

What is the regulatory landscape for the Glucose IV Bag market?

The regulatory landscape is characterized by strict guidelines and standards, ensuring product safety and quality.

Glucose IV Bag Market Growing at CAGR — 2026 Report

Glucose IV Bag by Application (Hospitals, Clinics, Others), by Types (50ml, 100ml, 500ml, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $8.6 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Glucose IV Bag Market Overview

The Glucose IV Bag market refers to the global marketplace for intravenous glucose bags, which are essential for providing hydration and nutrition to patients. As a crucial component of medical treatment, the Glucose IV Bag market size is expected to experience significant growth, driven by an increasing demand for intravenous therapy and a rising prevalence of chronic diseases. The growth outlook for the Glucose IV Bag market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 5-7% during the forecast period from 2026 to 2033. The current Glucose IV Bag market size is approximately $1.3 billion, with the global market expected to reach $2.5 billion by 2033. The industry expansion is driven by advancements in medical technology, an aging population, and an increase in hospital admissions.

Loading chart…

The Glucose IV Bag market is shaped by several key forces, including technology shifts towards more efficient and safe IV bag manufacturing processes, regulations that ensure the quality and sterility of IV bags, and consumer behavior that demands more convenient and user-friendly medical products. The largest region for the Glucose IV Bag market is North America, while the fastest-growing region is Asia-Pacific, driven by an increasing demand for healthcare services and a growing population. The competitive intensity in the market is moderate, with several major players competing for market share, including B. Braun, Baxter, and Hospira.

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.00 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter; Kelun Group; Fresenius Kabi; B Braun; SSY Group; CR Double-Cran; Otsuka; ICU Medical; Cisen Pharmaceutical; Huaren Pharmaceutical; Zhejiang Chimin
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Glucose IV Bag market is experiencing significant fluctuations due to various market dynamics. Understanding these factors is crucial for stakeholders to navigate the market effectively and capitalize on emerging trends.

Growth Drivers2 items

Increasing demand for glucose intravenous solutions in emergency care and critical care settings is driving the growth of the Glucose IV Bag market, with the market size expected to expand rapidly over the forecast period.

Advances in intravenous therapy and the development of more efficient glucose delivery systems are further propelling the market forward, contributing to a positive growth forecast.

Restraints2 items

Stringent regulatory requirements and fluctuating raw material prices are posing challenges to manufacturers, potentially limiting the growth of the Glucose IV Bag market size.

Competition from alternative nutrient delivery methods, such as oral supplements, may also hinder market expansion and impact the overall growth forecast.

Opportunities2 items

The increasing prevalence of chronic diseases, such as diabetes, is creating new opportunities for the Glucose IV Bag market, as glucose intravenous solutions become more essential in patient care.

Growing demand from emerging economies, where access to intravenous therapy is expanding, presents a significant opportunity for market players to increase their share of the Glucose IV Bag market size.

Challenges2 items

Maintaining sterility and preventing contamination during the manufacturing process of Glucose IV Bags is a significant challenge, requiring substantial investment in quality control measures.

Fluctuations in global demand and supply chain disruptions can impact the availability of Glucose IV Bags, affecting the growth forecast and overall market stability.

Market Segmentation

Loading chart…

The Application segment of the Glucose IV Bag market refers to the various uses of glucose IV bags in medical settings. This segment is crucial in understanding the Glucose IV Bag segmentation as it highlights the different areas where these bags are utilized, such as in the treatment of dehydration, insulin therapy, and as a source of energy for patients who cannot consume food orally. The application segment contributes significantly to the overall Glucose IV Bag market size, with its subtypes including pediatric care, adult care, and geriatric care, each having distinct requirements and demand patterns.

The Types segment of the Glucose IV Bag market encompasses the different subtypes of glucose IV bags available, such as 5% glucose, 10% glucose, and 50% glucose solutions. Each subtype has its own set of applications and is used in specific medical conditions. Understanding the market taxonomy of these types is essential for manufacturers and suppliers to cater to the diverse needs of healthcare providers. The types segment plays a vital role in determining the overall Glucose IV Bag market size, with factors such as concentration, volume, and compatibility with other medications influencing demand.

Glucose IV Bag Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

50ml

100ml

500ml

Other

Regional Insights

Loading chart…

The Glucose IV Bag market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and also the fastest-growing region, driven by increasing adoption of glucose IV bags in hospitals and clinics. Key drivers for this region include investments in healthcare infrastructure, a large demographics of patients requiring intravenous therapy, and a mature ecosystem supporting the production and distribution of glucose IV bags.

In North America, key drivers include policies supporting the use of glucose IV bags, a well-established infrastructure for healthcare, and a high level of adoption of advanced medical technologies. Europe is driven by investments in research and development, a strong ecosystem of pharmaceutical and medical device companies, and a large demographics of patients with chronic diseases. Latin America and Middle East & Africa are driven by increasing adoption of glucose IV bags, investments in healthcare infrastructure, and a growing demographics of patients requiring intravenous therapy.

The regional forecast indicates that Asia Pacific will continue to dominate the Glucose IV Bag market, with a regional forecast of high growth rates. The regional analysis suggests that North America and Europe will experience moderate growth, while Latin America and Middle East & Africa will experience high growth rates, driven by increasing adoption and investments in healthcare infrastructure.

Competitive Landscape

The Glucose IV Bag market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Glucose IV Bag competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolio and channel strength. Understanding the market's competitive dynamics is crucial for companies to navigate the complex Glucose IV Bag key players and their strategies.

Companies in the Glucose IV Bag market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

Baxter: regional expansion

Kelun Group: vertical integration

Fresenius Kabi: premium pricing

B Braun: OEM tie-ups

SSY Group: innovation pipeline

CR Double-Cran: local manufacturing

Key Glucose IV Bag Companies11 items

Baxter

Kelun Group

Fresenius Kabi

B Braun

SSY Group

CR Double-Cran

Otsuka

ICU Medical

Cisen Pharmaceutical

Huaren Pharmaceutical

Zhejiang Chimin

Market Ecosystem

The Glucose IV Bag ecosystem encompasses a complex network of participants, spanning from upstream suppliers to downstream end users. This ecosystem can be broadly segmented into three primary stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and consumed. The value chain analysis of the Glucose IV Bag ecosystem reveals how value is created and captured at each stage, from the production of glucose and other essential components to the delivery of finished products to healthcare facilities.

Raw material suppliers — provide glucose and other essential components

OEMs / manufacturers — produce Glucose IV Bags

Distributors / channel partners — deliver products to healthcare facilities

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer maintenance and support services

Data/analytics providers — provide insights on usage and outcomes

The flow of value within the Glucose IV Bag ecosystem is influenced by various control points, including regulatory approvals, supply chain dependencies, and partnerships between manufacturers and distributors. Dependency risks, such as input constraints and standards compliance, can impact the availability and quality of Glucose IV Bags. Furthermore, switching costs and interoperability requirements may limit the flexibility of end users to choose between different products and suppliers. The Glucose IV Bag ecosystem may differ by region, with varying regulatory requirements, market conditions, and healthcare infrastructure influencing the dynamics of value creation and capture.

Recent Industry Insights

The Glucose IV Bag industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product offerings and expanding distribution networks. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several companies have launched new products and technologies, prioritizing improved safety features and user convenience.

In addition to these advancements, regulatory changes have emphasized the importance of strict quality control measures and adherence to industry standards. A shift in consumer and enterprise trends has been observed, with a growing emphasis on sustainable and environmentally friendly packaging solutions. Moreover, funding rounds and expansions have enabled companies to invest in research and development, driving innovation in the Glucose IV Bag industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Glucose IV Bag market. The market attractiveness of this sector is moderate, driven by the increasing demand for intravenous solutions in healthcare settings. The competitive intensity is high, with several key players competing for market share. Looking at the long-term Glucose IV Bag market outlook, we anticipate steady growth due to the rising prevalence of chronic diseases and the expanding use of IV therapies. The innovation landscape is characterized by advancements in packaging and formulation technologies. However, the demand–supply balance may be affected by fluctuations in raw material availability and regulatory changes. Key risk factors include supply chain disruptions and stringent regulatory requirements.

12 items

1. Executive Summary

2. Glucose IV Bag Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glucose IV Bag Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glucose IV Bag Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glucose IV Bag Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Glucose IV Bag Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Glucose IV Bag Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glucose IV Bag Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glucose IV Bag Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Glucose IV Bag Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Glucose IV Bag Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glucose IV Bag Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glucose IV Bag Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Glucose IV Bag Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glucose IV Bag Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Glucose IV Bag Market Competition by Key Manufacturers

9.1. Global Glucose IV Bag Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glucose IV Bag: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Baxter

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Kelun Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fresenius Kabi

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. SSY Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CR Double-Cran

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Otsuka

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. ICU Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cisen Pharmaceutical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Huaren Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Zhejiang Chimin

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glucose IV Bag Market

Figure 4: Global Glucose IV Bag Market: Drivers

Figure 5: Global Glucose IV Bag Market: Challenges

Figure 6: Global Glucose IV Bag Market: Trends

Figure 7: Global Glucose IV Bag Market: Opportunity

Figure 8: Global Glucose IV Bag Market: Restraint

Figure 9: Global Glucose IV Bag Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Glucose IV Bag Market Value (USD Million) By Region

Figure 19: Global Glucose IV Bag Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Glucose IV Bag Market Value (USD Million) By Region

Figure 27: Global Glucose IV Bag Market Share (%) By: Regions (2032)

Figure 28: Global Glucose IV Bag Market Volume (K) By Region

Figure 29: Global Glucose IV Bag Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Glucose IV Bag Market Value (USD Million) By Region

Figure 37: Global Glucose IV Bag Market Share (%) By: Regions (2032)

Figure 38: Global Glucose IV Bag Market Volume (K) By Region

Figure 39: Global Glucose IV Bag Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Glucose IV Bag Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Glucose IV Bag Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Glucose IV Bag Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Glucose IV Bag Market Value (USD Million) By Region

Table 14: Global Glucose IV Bag Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Glucose IV Bag Market Volume (K) By Region

Table 31: Global Glucose IV Bag Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Glucose IV Bag Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glucose IV Bag Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glucose IV Bag Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Baxter Basic Information And Sales Area

Table 52: Baxter. Products Portfolio

Table 53: Kelun Group Basic Information And Sales Area

Table 54: Kelun Group. Products Portfolio

Table 55: Fresenius Kabi Basic Information And Sales Area

Table 56: Fresenius Kabi. Products Portfolio

Table 57: B Braun Basic Information And Sales Area

Table 58: B Braun. Products Portfolio

Table 59: SSY Group Basic Information And Sales Area

Table 60: SSY Group. Products Portfolio

Table 61: CR Double-Cran Basic Information And Sales Area

Table 62: CR Double-Cran. Products Portfolio

Table 63: Otsuka Basic Information And Sales Area

Table 64: Otsuka. Products Portfolio

Table 65: ICU Medical Basic Information And Sales Area

Table 66: ICU Medical. Products Portfolio

Table 67: Cisen Pharmaceutical Basic Information And Sales Area

Table 68: Cisen Pharmaceutical. Products Portfolio

Table 69: Huaren Pharmaceutical Basic Information And Sales Area

Table 70: Huaren Pharmaceutical. Products Portfolio

Table 71: Zhejiang Chimin Basic Information And Sales Area

Table 72: Zhejiang Chimin. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Glucose IV Bag Market Value (USD Million) By Region

Table 82: Global Glucose IV Bag Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Glucose IV Bag Market Volume (K) By Region

Table 99: Global Glucose IV Bag Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Glucose IV Bag Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.60 million
Revenue forecast in 2033	15.00 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Baxter; Kelun Group; Fresenius Kabi; B Braun; SSY Group; CR Double-Cran; Otsuka; ICU Medical; Cisen Pharmaceutical; Huaren Pharmaceutical; Zhejiang Chimin
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in intravenous therapy and the development of more efficient glucose delivery systems are further propelling the market forward, contributing to a positive growth forecast.

Restraints2 items

Stringent regulatory requirements and fluctuating raw material prices are posing challenges to manufacturers, potentially limiting the growth of the Glucose IV Bag market size.

Competition from alternative nutrient delivery methods, such as oral supplements, may also hinder market expansion and impact the overall growth forecast.

Opportunities2 items

Challenges2 items

Maintaining sterility and preventing contamination during the manufacturing process of Glucose IV Bags is a significant challenge, requiring substantial investment in quality control measures.

Fluctuations in global demand and supply chain disruptions can impact the availability of Glucose IV Bags, affecting the growth forecast and overall market stability.

Market Segmentation

Loading chart…

Glucose IV Bag Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

50ml

100ml

500ml

Other

Regional Insights

Loading chart…

Competitive Landscape

Baxter: regional expansion

Kelun Group: vertical integration

Fresenius Kabi: premium pricing

B Braun: OEM tie-ups

SSY Group: innovation pipeline

CR Double-Cran: local manufacturing

Key Glucose IV Bag Companies11 items

Baxter

Kelun Group

Fresenius Kabi

B Braun

SSY Group

CR Double-Cran

Otsuka

ICU Medical

Cisen Pharmaceutical

Huaren Pharmaceutical

Zhejiang Chimin

Market Ecosystem

Raw material suppliers — provide glucose and other essential components

OEMs / manufacturers — produce Glucose IV Bags

Distributors / channel partners — deliver products to healthcare facilities

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish safety and efficacy standards

Service providers / after-sales — offer maintenance and support services

Data/analytics providers — provide insights on usage and outcomes

Recent Industry Insights

Analyst Overview

Table of Contents